XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 1 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $43,000 | -77.6% | 17,546 | -62.8% | 0.00% | -50.0% |
| Q2 2021 | $192,000 | -30.2% | 47,230 | -22.6% | 0.00% | -50.0% |
| Q1 2021 | $275,000 | +23.3% | 61,015 | +34.4% | 0.00% | +33.3% |
| Q4 2020 | $223,000 | -13.6% | 45,397 | +76.7% | 0.00% | -62.5% |
| Q1 2019 | $258,000 | +2050.0% | 25,693 | +3883.4% | 0.01% | +700.0% |
| Q2 2018 | $12,000 | – | 645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crawford Lake Capital Management, LLC | 72,493 | $4,160,000 | 0.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,583,291 | $18,212,000 | 0.58% |
| Redmile Group, LLC | 3,000,641 | $21,155,000 | 0.51% |
| ArrowMark Colorado Holdings LLC | 1,928,308 | $13,595,000 | 0.12% |
| IHT Wealth Management, LLC | 90,675 | $639,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 47,578 | $335,000 | 0.04% |
| Blackstone Inc. | 450,000 | $3,173,000 | 0.02% |
| Crawford Lake Capital Management, LLC | 2,000 | $115,000 | 0.02% |
| MOORE CAPITAL MANAGEMENT, LP | 50,000 | $353,000 | 0.01% |
| CITIGROUP INC | 2,201,839 | $15,523,000 | 0.01% |